UBS Group assumed coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Free Report) in a research note published on Friday, MarketBeat Ratings reports. The firm issued a buy rating and a $21.00 price target on the stock.
Telix Pharmaceuticals Limited American Depositary Shares Stock Down 2.0 %
Shares of TLX stock traded down $0.30 during trading hours on Friday, reaching $14.85. The stock had a trading volume of 40,166 shares. Telix Pharmaceuticals Limited American Depositary Shares has a twelve month low of $14.81 and a twelve month high of $19.99.
Featured Stories
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- Earnings Per Share Calculator: How to Calculate EPS
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Golden Cross Stocks: Pattern, Examples and Charts
- Time to Load Up on Home Builders?
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
